Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Cyclophosphamide/Methylprednisolone/Prednisone

Obesity, adrenal insufficiency and rebound effect

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Rydin A, et al. Autoimmune Brain Disease Associated with Severe Obesity and Progressive Hypothalamic and Pituitary Dysfunction. Journal of the Endocrine Society 13 (Suppl. 1): abstr. SUN-285, Apr 2019. Available from: URL: https://dx.doi.org/10.1210/js.2019-SUN-285 [abstract] Rydin A, et al. Autoimmune Brain Disease Associated with Severe Obesity and Progressive Hypothalamic and Pituitary Dysfunction. Journal of the Endocrine Society 13 (Suppl. 1): abstr. SUN-285, Apr 2019. Available from: URL: https://dx.doi.org/10.1210/js.2019-SUN-285 [abstract]
Metadaten
Titel
Cyclophosphamide/Methylprednisolone/Prednisone
Obesity, adrenal insufficiency and rebound effect
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56789-z

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Ofatumumab

Case report

Metformin

Case report

Multiple drug

Case report

Donepezil